×
About 84,310 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  27,454 results

Genetic trade-offs between complex diseases and longevity.
https://doi.org/10.1111/acel.13654
Aging Cell; Hu D, Li Y et. al.

Jun 28th, 2022 - Longevity was influenced by many complex diseases and traits. However, the relationships between human longevity and genetic risks of complex diseases were not broadly studied. Here, we constructed polygenic risk scores (PRSs) for 225 complex dise...

GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear...
https://doi.org/10.1093/schbul/sbac069
Schizophrenia Bulletin; Petrikis P, Polyzou A et. al.

Jun 28th, 2022 - Schizophrenia is characterized by a complex interplay between genetic and environmental risk factors converging on prominent signaling pathways that orchestrate brain development. The Akt/GSK3β/mTORC1 pathway has long been recognized as a point of...

Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia.
https://doi.org/10.1176/appi.ajp.21101083
The American Journal of Psychiatry; Paul SM, Yohn SE et. al.

Jun 28th, 2022 - Schizophrenia remains a challenging disease to treat effectively with current antipsychotic medications due to their limited efficacy across the entire spectrum of core symptoms as well as their often burdensome side-effect profiles and poor toler...

Updated perspectives on the clinical significance of negative symptoms in patients with...
https://doi.org/10.1080/14737175.2022.2092402
Expert Review of Neurotherapeutics; Giordano GM, Caporusso E et. al.

Jun 28th, 2022 - Negative symptoms in schizophrenia are associated with poor response to available treatments, poor quality of life, and functional outcome. Therefore, they represent a substantial burden for people with schizophrenia, their families, and health-ca...

Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Re...
https://doi.org/10.1001/jamanetworkopen.2022.18730
JAMA Network Open; Wang B, Huskamp HA et. al.

Jun 28th, 2022 - Access to specialty mental health care remains challenging for people with serious mental illnesses, such as schizophrenia and bipolar disorder. Whether expansion of telemedicine is associated with improved access and quality of care for these pat...

see more →

Guidelines  10 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 2nd, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
https://doi.org/10.1177/0269881119889296
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 13th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascu...
https://doi.org/10.1177/0269881116645254
Journal of Psychopharmacology (Oxford, England); Cooper SJ, Reynolds GP et. al.

May 6th, 2016 - Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabe...

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biologica...
https://doi.org/10.3109/15622975.2012.696143
The World Journal of Biological Psychiatry : the Official... Hasan A, Falkai P et. al.

Jul 28th, 2012 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaini...

see more →

Drugs  951 results see all →

Clinicaltrials.gov  2,941 results

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
https://clinicaltrials.gov/ct2/show/NCT04624243

Jun 24th, 2022 - The purpose of this study is to evaluate the efficacy and safety of MK-8189 at a range of doses (8 mg, 16 mg, and 24 mg once daily) in adult participants who have an acute episode of schizophrenia according to Diagnostic and Statistical Manual of ...

Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents
https://clinicaltrials.gov/ct2/show/NCT05431517

Jun 24th, 2022 - Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pancreatic pseudocyst drainage, and prophylactic ...

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)
https://clinicaltrials.gov/ct2/show/NCT04659161

Jun 24th, 2022 - This is a Phase 3, randomized, double-blind, parallel-group, placebo-controlled, multicenter inpatient study to examine the efficacy and safety of KarXT in adult subjects who are acutely psychotic with a Diagnostic and Statistical Manual Fifth Edi...

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
https://clinicaltrials.gov/ct2/show/NCT00942981

Jun 24th, 2022 - OBJECTIVES Dopaminergic (DA) modulation of brain function is disturbed in several disabling psychiatric disorders and represents the target of key psychopharmacologic agents, such as neuroleptics. Schizophrenia has been considered a prototype of d...

Inpatient Evaluation of Adults With Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT00001247

Jun 24th, 2022 - Objectives: Schizophrenia and related psychoses are chronic brain disorders whose prognosis is often poor and whose pathophysiology remains obscure. Neuroimaging technologies such as PET (positron emission tomography), fMRI (functional magnetic re...

see more →

News  2,356 results

Sleep a Potential Treatment Target for Schizophrenia?
https://www.medscape.com/viewarticle/976216

Jun 27th, 2022 - A new analysis reveals a bidirectional relationship between sleep patterns and schizophrenia, leading researchers to suggest that sleep may be a potential treatment target for the disorder. Applying a Mendelian randomization (MR) approach, the inv...

Transdermal Med May Directly Target Hostility in Schizophrenia
https://www.medscape.com/viewarticle/976028

Jun 22nd, 2022 - HP-3070, an asenapine transdermal system, is superior to placebo in reducing schizophrenia-associated hostility, results of a phase 3 study show. The results suggest that these effects are at least partially independent of general antipsychotic ef...

Broccoli Reigns Supreme As America's Favorite Veggie
https://www.medscape.com/viewarticle/975951

Jun 21st, 2022 - "I'm President of the United States, and I'm not going to eat any more broccoli." That was what then-President George H.W. Bush said in 1990, famously declaring his hatred for the tree-like cruciferous vegetable. Turns out, Americans in 2022 do no...

Advance Directives for Psychiatric Care Reduce Compulsory Admissions
https://www.medscape.com/viewarticle/975938

Jun 21st, 2022 - Providing peer or community health workers to help psychiatric patients with complete psychiatric advance directives (PAD) to govern care in advance of a mental health crisis is associated with a significant reduction in compulsory hospital admiss...

FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis
https://www.medscape.com/viewarticle/975874

Jun 17th, 2022 - A US Food and Drug Administration (FDA) advisory panel has rejected the atypical antipsychotic pimavanserin (Nuplazid, Acadia Pharmaceuticals) for the treatment of Alzheimer's disease psychosis (ADP). In a 9-3 vote, the Psychopharmacologic Drugs A...

see more →

Patient Education  12 results see all →